# wombat urls ß PLOS Medicine: Antigenic Fingerprinting of H5N1 Avian Influenza Using Convalescent Sera and Monoclonal Antibodies Reveals Potential Vaccine and Diagnostic Targets
Advertisement
Research Article

Antigenic Fingerprinting of H5N1 Avian Influenza Using Convalescent Sera and Monoclonal Antibodies Reveals Potential Vaccine and Diagnostic Targets

  • Surender Khurana,

    Affiliation: Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Bethesda, Maryland, United States of America

    X
  • Amorsolo L. Suguitan Jr.,

    Affiliation: Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Yonaira Rivera,

    Affiliation: Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Bethesda, Maryland, United States of America

    X
  • Cameron P. Simmons,

    Affiliation: Oxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam

    X
  • Antonio Lanzavecchia,

    Affiliation: Institute for Research in Biomedicine, Bellinzona, Switzerland

    X
  • Federica Sallusto,

    Affiliation: Institute for Research in Biomedicine, Bellinzona, Switzerland

    X
  • Jody Manischewitz,

    Affiliation: Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Bethesda, Maryland, United States of America

    X
  • Lisa R. King,

    Affiliation: Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Bethesda, Maryland, United States of America

    X
  • Kanta Subbarao,

    Affiliation: Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Hana Golding mail

    hana.golding@fda.hhs.gov

    Affiliation: Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Bethesda, Maryland, United States of America

    X
  • Published: April 21, 2009
  • DOI: 10.1371/journal.pmed.1000049

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.